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Coronary computed tomographic angiography (CCTA) is
evolving into a mature imaging modality for assessment of
patients with acute chest pain in the emergency department
(ED). More than 1,000 patients have been studied in the
ED setting in both single-center and multicenter trials, not
including the results of the CT-STAT (Coronary Com-
puted Tomographic Angiography for Systematic Triage of
Acute Chest Pain Patients to Treatment) trial published by
Goldstein et al. (1) in this issue of the Journal. The results
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of these prior studies demonstrate a pooled sensitivity of
92%, specificity of 89%, and a very high negative predictive
value (NPV) of 99% (2). The positive predictive values for
detecting significant coronary artery disease (CAD) have
been moderate, ranging from 33% to 95% with a pooled
estimate of 48%. Furthermore, the concordance between
obstructive CAD by CCTA, and ischemia by myocardial
perfusion imaging (MPI) has been low, ranging from 29%
to 44% (3). However, because of its excellent NPV, CCTA
has been particularly useful to exclude significant stenoses in
patients presenting to the ED with chest pain and low-
intermediate likelihood of CAD. Several studies have dem-
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to the contents of this paper to disclose.onstrated very low event rates at 1 year of follow-up in
patients either without CAD or with minimal nonobstruc-
tive plaque (4). As CCTA can be performed rapidly, it has
the potential to significantly impact the triage of chest pain
patients in the ED. Myocardial perfusion imaging has been
the predominant noninvasive approach to detecting CAD
among chest pain patients (5).
The findings of the multicenter CT-STAT trial (1)
confirm the single-center study by Goldstein et al. (6). In
the multicenter trial, 361 patients with acute chest pain in
the ED were randomly assigned to CCTA and 338 to
single-positron emission computed tomography (SPECT)
MPI. The CCTA strategy resulted in a 54% reduction in
time to diagnosis compared with MPI (2.9 h vs. 6.3 h), and
costs of care were 38% lower for the CCTA group. The 2
strategies showed no difference in freedom from major
adverse cardiac events at 6 months of follow-up.
It is notable that the CT-STAT study utilized a rest-
stress MPI protocol that may have contributed to both the
longer time to diagnosis and the cost for the stress imaging
strategy. While this was the typical protocol for MPI in the
centers included in the trial at the time, in recent years, EDs
and chest pain centers are increasingly utilizing stress-only
protocols for low-risk patients without acute electrocardi-
ography (ECG) changes. Stress-only MPI protocols have
been evaluated in several studies with large patient popula-
tions, and no significant differences in mortality have been
found for patients with a normal stress-only study as
compared with patients who had normal rest-stress study
(7). Thus, an additional rest MPI is not necessary in patients
who have a normal initial gated-stress MPI study. Had such
a protocol been used in the CT-STAT study, the time to
diagnosis would have been substantially shortened, as 89.9%
of the patients in the SPECT arm had normal MPI studies.
Several technical advances are improving the ability of
SPECT MPI to diagnose ischemia faster and include
ultrafast cameras that employ innovative gantry designs,
cadmium zinc telluride solid-state detectors, and novel
iterative reconstruction algorithms that enable rest and
stress imaging to each be performed in5 min (8,9). Use of
such ultrafast SPECT cameras would further decrease the
time to diagnosis of CAD for patients being evaluated for
chest pain in the ED.
Alternatively, an exercise ECG stress test alone with-
out concomitant cardiac imaging would be feasible for
patients at very low risk for an acute coronary syndrome
(ACS) and who likely have very good functional capacity.
We found that in patients who achieved a high workload
(i.e., 10 metabolic equivalents) without ST-segment
depression, the prevalence of significant ischemia com-
prising 10% or more of the left ventricle by MPI was 0%,
with only 1 cardiac death during 2.6 years of follow-up
(10,11). This strategy would likely be more cost-effective
than any imaging strategy.
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(1) was a reduced radiation dose compared with SPECT.
The radiation doses of both CCTA and SPECT MPI
studies have dropped significantly with equipment and
protocol advancements. Several radiation dose-sparing
strategies for CCTA, including tube current modulation,
reduced tube voltage for nonobese patients, and prospective
gating techniques, have been widely employed in clinical
practice. However, it is important to note that these
strategies have limitations in subjects who have elevated
body mass index (35 kg/m2), elevated heart rate (70
beats/min), or irregular heart rates. New technologies such
as 320-row detector computed tomography can perform a
CCTA in a single heart beat at a dose of approximately 4 to
5 mSv (12). Recently, high-pitch coronary protocols using a
dual-source CCTA scanner have demonstrated doses of 1
to 2 mSv (13). The radiation dose with radionuclide MPI
has also been dropping, and newer ultrafast cameras have
doses as low as 4.2 mSv for a stress-only protocol (8). Even
with older equipment, a stress-only protocol would signif-
icantly reduce radiation dose. Thus, using the most up-to-
date CCTA protocols, and employing stress-only MPI
protocols, both arms of this study would expose patients to
a significantly lower radiation dosage.
The ongoing PROMISE (Prospective Multicenter Im-
aging Study for Evaluation of Chest Pain) trial, which is the
largest National Institutes of Health–sponsored multicenter
comparative effectiveness imaging trial with a targeted
enrollment of 10,000, will provide further insight into the
diagnostic accuracy and cost-effectiveness of a diagnostic
strategy using an anatomic assessment with CCTA versus a
functional assessment with conventional stress testing. Al-
though this study is not in the ED setting, it will provide
important additional information about the relative merits
of using an anatomical versus functional assessment for
diagnosing CAD.
A few areas of active research may further improve the
diagnostic utility of CCTA. Stress perfusion imaging using
CCTA has shown promise, but to date these protocols have
significant radiation burden (14). Plaque characterization
may improve the diagnostic utility of CCTA; however,
these techniques are still in the development and clinical
validation stage (15). Molecular imaging with positron-
emission tomography (PET)–computed tomography may
also hold potential for identifying inflammation and detect-
ing vulnerable plaques (16), and could provide a compre-
hensive assessment of both coronary anatomy, and myocar-
dial perfusion (17).
Other imaging techniques hold promise for the detection
of CAD and ACS in patients presenting to the ED with
chest pain. Cardiac magnetic resonance (CMR) has been
shown to accurately identify patients with possible ACS
with a sensitivity and specificity for detecting ACS of using
resting perfusion, ventricular function, and gadolinium en-
hancement of 84% and 85%, respectively (18). The addition
of edema imaging increased the specificity, positive predic-tive value, and overall accuracy to 96%, 85%, and 93%,
respectively (19). Furthermore, patients with a normal
adenosine stress study had no subsequent diagnosis of CAD
or major adverse cardiac events at 1 year (20). A recent
comparison of 32-channel 3-T coronary magnetic reso-
nance angiography versus 64-slice CCTA demonstrated
similar diagnostic accuracy for detecting obstructive CAD,
and both techniques identified all cases of left main and
3-vessel disease (21). Thus, CMR can provide a compre-
hensive assessment of function and coronary anatomy.
Minimal data are available for assessing PET MPI in the
ED setting; however, PET is associated with lower radia-
tion doses (from 2 mSv for 13NH3 to 3.7 mSv for a
82Rb
MPI [22]), improved data acquisition efficiency (rest-stress
Rb-82 PET MPI study can be performed in 15 min), and
improved diagnostic accuracy and certainty as compared
with SPECT MPI (23). Although PET is more costly than
SPECT, the overall cost of this diagnostic strategy is
unclear, as it may reduce additional testing from the
improved test characteristics.
In summary, the CT-STAT trial provides additional evi-
dence for the excellent NPV of CCTA in patients at low risk
for an ACS or at low-intermediate risk of having CAD as the
cause of the chest pain syndrome, and who are eligible for this
imaging approach. A substantial number of patients presenting
with chest pain in the ED, as described by Goldstein et al. (1),
are not eligible for CCTA or would benefit more from a
functional imaging approach. Advances in both CCTA and
MPI are improving the diagnostic accuracy of these imaging
technologies, with concomitant reduction in radiation expo-
sure. Both the anatomic diagnostic strategy and the physiologic
stress imaging strategy yield similar outcomes with respect to
predicting cardiac events. The true differences in time to
diagnosis and costs between these 2 approaches will be deter-
mined in future studies that employ such state-of-the-art
technology and with enhanced interpretive experience of phy-
sicians reading these studies. Other technologies such as CMR
and contrast echocardiography may also play a future role in
this patient population. Finally, it should be emphasized that
the most cost-effective strategy is exercise ECG testing alone as
the first test, with no imaging performed for patients with
atypical chest pain, patients with a normal resting ECG, and
patients who attain high exercise heart rates and workloads
without associated ischemic ST-segment depression.
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